Filing Details

Accession Number:
0001144204-12-006181
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-06 18:03:51
Reporting Period:
2012-02-02
Filing Date:
2012-02-06
Accepted Time:
2012-02-06 18:03:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124608 Response Genetics Inc RGDX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1431872 Richard Broek Den Van C/O Response Genetics, Inc
1640 Marengo St., 6Th Floor
Los Angeles CA 90033
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2012-02-02 100,000 $1.50 282,700 No 4 P Indirect By HSMR Capital Partners, (QP) LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By HSMR Capital Partners, (QP) LP
Footnotes
  1. This number represents 100,000 shares of Common Stock purchased by HSMR Capital Partners, (QP) LP on February 2, 2012. See note 2 for a description of Mr. van den Broek's affiliation with HSMR Capital Partners, (QP) LP.
  2. This number represents 282,700 shares of Common Stock held by HSMR Capital Partners, (QP) LP following the reported transaction. Mr. van den Broek is the Managing Member of HSMR Advisors, LLC, which is the General Partner of HSMR Capital Partners, (QP) LP. By virtue of his position with the General Partner of HSMR Capital Partners, (QP) LP, Mr. van den Broek has the power to vote and dispose of the reported securities owned by HSMR Capital Partners, (QP) LP. Mr. van den Broek disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.